Short Versus Long-Term Dual Antiplatelet Therapy in Patients at High Bleeding Risk Undergoing PCI in Contemporary Practice: A Systemic Review and Meta-analysis

Short Versus Long-Term Dual Antiplatelet Therapy in Patients at High Bleeding Risk Undergoing PCI in Contemporary Practice: A Systemic Review and Meta-analysis

Abstract Introduction Patients at high bleeding risk (HBR patients) represent an important subset of patients undergoing percutaneous coronary intervention (PCI). It remains unclear whether a shortened duration of dual antiplatelet therapy (DAPT) confers benefits compared with prolonged duration of...

Full description

Bibliographic Details
Main Authors: Nader Mankerious, Michael Megaly, Rayyan Hemetsberger, Abdelhakim Allali, Mohamed Samy, Ralph Toelg, Santiago Garcia, Gert Richardt
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-06-01
Series:Cardiology and Therapy
Subjects:
High bleeding risk
Dual antiplatelet therapy
Percutaneous coronary intervention
Online Access:https://doi.org/10.1007/s40119-023-00318-5

Internet

https://doi.org/10.1007/s40119-023-00318-5

Similar Items